About the Authors

Elena-Raluca Nicoli

Contributed equally to this work with: Elena-Raluca Nicoli, Nada Al Eisa, Celine V. M. Cluzeau

Affiliation Department of Pharmacology, University of Oxford, Oxford, United Kingdom

Nada Al Eisa

Contributed equally to this work with: Elena-Raluca Nicoli, Nada Al Eisa, Celine V. M. Cluzeau

Affiliation Department of Pharmacology, University of Oxford, Oxford, United Kingdom

Celine V. M. Cluzeau

Contributed equally to this work with: Elena-Raluca Nicoli, Nada Al Eisa, Celine V. M. Cluzeau

Affiliation Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

Christopher A. Wassif

Affiliations Department of Pharmacology, University of Oxford, Oxford, United Kingdom, Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

James Gray

Affiliation Department of Pharmacology, University of Oxford, Oxford, United Kingdom

Kathryn R. Burkert

Affiliation Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

David A. Smith

Affiliation Department of Pharmacology, University of Oxford, Oxford, United Kingdom

Lauren Morris

Affiliation Department of Pharmacology, University of Oxford, Oxford, United Kingdom

Stephanie M. Cologna

Affiliation Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

Cody J. Peer

Affiliation Clinical Pharmacology Program, Medical Oncology Branch, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America

Tristan M. Sissung

Affiliation Clinical Pharmacology Program, Medical Oncology Branch, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America

Constantin-Daniel Uscatu

Affiliations Department of Pharmacology, University of Oxford, Oxford, United Kingdom, Department of Cellular and Molecular Biology, University of Medicine and Pharmacy of Craiova, Craiova, Romania

William D. Figg

Affiliation Clinical Pharmacology Program, Medical Oncology Branch, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America

William J. Pavan

Affiliation Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

Charles H. Vite

Affiliation School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

Forbes D. Porter

Frances.platt@pharm.ox.ac.uk (FMP); fdporter@mail.nih.gov (FDP)

Affiliation Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

Frances M. Platt

Frances.platt@pharm.ox.ac.uk (FMP); fdporter@mail.nih.gov (FDP)

Affiliation Department of Pharmacology, University of Oxford, Oxford, United Kingdom

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: ERN NA CVMC CAW WDF CHV FDP FMP. Performed the experiments: ERN NA CVMC CAW JG KRB DAS SMC CJP TMS CDU WJP CHV. Analyzed the data: ERN NA CVMC CAW JG SMC CJP TMS CDU WDF WJP CHV FDP FMP. Contributed reagents/materials/analysis tools: WDF WJP CHV FDP FMP. Wrote the paper: ERN NA CVMC CAW SMC WDF WJP CHV FDP FMP. Relevant mouse studies were conducted: DAS LM.